Monitoring tumor response to the vascular disrupting agent CKD-516 in a rabbit VX2 intramuscular tumor model using PET/MRI: Simultaneous evaluation of vascular and metabolic parameters-Reference-Cited by-同舟云学术

Monitoring tumor response to the vascular disrupting agent CKD-516 in a rabbit VX2 intramuscular tumor model using PET/MRI: Simultaneous evaluation of vascular and metabolic parameters

Published:2018-02-13 Issue:2 Volume:13 Page:e0192706
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ahn Su Yeon,Goo Jin Mo^ORCID,Lee Kyung Hee,Ha Seunggyun,Paeng Jin Chul

Funder

National Research Foundation of Korea

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents;JP O’Connor;Br J Cancer,2007

2. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1);EA Eisenhauer;Eur J Cancer,2009

3. Imaging angiogenesis: applications and potential for drug development;JC Miller;J Natl Cancer Inst,2005

4. Multiparametric imaging of tumor response to therapy;AR Padhani;Radiology,2010

5. Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy;IM Desar;Cancer Treat Rev,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of a modified percutaneous CT-guided paraspinal intramuscular VX-2 squamous cell carcinoma dual tumor model in rabbits;PeerJ;2021-05-28

2. Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors;Molecules;2021-04-27

3. Involvement of ER stress and reactive oxygen species generation in anti-cancer effect of CKD-516 for lung cancer;Cancer Chemotherapy and Pharmacology;2020-03-11